These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 15719699)
1. The use of B-type natriuretic peptide in the diagnosis of acute dyspnoea. Mueller C; Laule-Kilian K; Christ A; Staub D Clin Lab; 2005; 51(1-2):5-9. PubMed ID: 15719699 [TBL] [Abstract][Full Text] [Related]
2. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure. Omland T Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473 [TBL] [Abstract][Full Text] [Related]
3. [B-type natriuretic peptide--current use in the diagnosis and management of heart failure]. Müller C; Kuster G; Büttner HJ; Buser P Herz; 2003 Aug; 28(5):374-9. PubMed ID: 12928736 [TBL] [Abstract][Full Text] [Related]
4. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea. van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498 [TBL] [Abstract][Full Text] [Related]
5. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease. Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921 [TBL] [Abstract][Full Text] [Related]
6. Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease. Mueller C; Laule-Kilian K; Frana B; Rodriguez D; Scholer A; Schindler C; Perruchoud AP Am Heart J; 2006 Feb; 151(2):471-7. PubMed ID: 16442916 [TBL] [Abstract][Full Text] [Related]
7. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients. Berdagué P; Caffin PY; Barazer I; Vergnes C; Sedighian S; Letrillard S; Pilossof R; Goutorbe F; Piot C; Reny JL Am Heart J; 2006 Mar; 151(3):690-8. PubMed ID: 16504634 [TBL] [Abstract][Full Text] [Related]
8. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population]. El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022 [TBL] [Abstract][Full Text] [Related]
9. The use of B-type natriuretic peptide in the management of elderly patients with acute dyspnoea. Mueller C; Laule-Kilian K; Frana B; Rodriguez D; Rudez J; Scholer A; Buser P; Pfisterer M; Perruchoud AP J Intern Med; 2005 Jul; 258(1):77-85. PubMed ID: 15953135 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Mueller T; Gegenhuber A; Poelz W; Haltmayer M Heart; 2005 May; 91(5):606-12. PubMed ID: 15831643 [TBL] [Abstract][Full Text] [Related]
13. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762 [TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department. Ray P; Delerme S; Jourdain P; Chenevier-Gobeaux C QJM; 2008 Nov; 101(11):831-43. PubMed ID: 18664534 [TBL] [Abstract][Full Text] [Related]
15. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms. Januzzi JL; Chen-Tournoux AA; Moe G Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855 [TBL] [Abstract][Full Text] [Related]
16. Brain natriuretic peptide in diagnosis and treatment of heart failure. Bhatia V; Nayyar P; Dhindsa S J Postgrad Med; 2003; 49(2):182-5. PubMed ID: 12867703 [TBL] [Abstract][Full Text] [Related]
17. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea. Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931 [TBL] [Abstract][Full Text] [Related]
18. B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure. Gegenhuber A; Mueller T; Dieplinger B; Poelz W; Pacher R; Haltmayer M Clin Chim Acta; 2006 Aug; 370(1-2):174-9. PubMed ID: 16600203 [TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic peptide: a diagnostic, prognostic, and therapeutic tool in heart failure. Prahash A; Lynch T Am J Crit Care; 2004 Jan; 13(1):46-53; quiz 54-5. PubMed ID: 14735647 [TBL] [Abstract][Full Text] [Related]